Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...
Aamir Khan and Ranbir Kapoor engage in playful banter in Dream 11's latest ad. The fun peaks when Ranbir, caught in a ...
An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted the ire of a pharmaceutical trade organisation that calls the campaign "nothing short ...
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against other stocks that outperform the broader market. Imagine choosing a group of stocks that ...
Hims & Hers Health experienced significant year-over-year growth in both downloads of its app and web traffic in February.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results